Andrew Obenshain Bluebird Bio, Inc. (BLUE) insider trading activity

BLUE Quotes by TradingView

Andrew Obenshain is President and CEO of bluebird bio, Inc.. Currently has a direct ownership of 374,247 shares of BLUE, which is worth approximately $2.87 Million. The most recent transaction as insider was on Dec 10, 2024, when has been sold 971 shares (Common Stock) at a price of $0.42 per share, resulting in proceeds of $407. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 374K
33.66% 3M change
28.55% 12M change
Total Value Held $2.87 Million

Andrew Obenshain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2024
SELL
Open market or private sale
$407 $0.42 p/Share
971 Reduced 0.26%
374,247 Common Stock
Sep 30 2024
SELL
Open market or private sale
$18,433 $0.53 p/Share
34,780 Reduced 8.48%
375,218 Common Stock
Sep 30 2024
BUY
Grant, award, or other acquisition
-
130,000 Added 24.07%
409,998 Common Stock
Mar 04 2024
SELL
Open market or private sale
$9,325 $1.53 p/Share
6,095 Reduced 2.13%
279,998 Common Stock
Feb 05 2024
SELL
Open market or private sale
$1,691 $0.9 p/Share
1,879 Reduced 0.65%
286,093 Common Stock
Jan 05 2024
SELL
Open market or private sale
$4,521 $1.43 p/Share
3,162 Reduced 1.09%
287,972 Common Stock
Nov 03 2023
SELL
Open market or private sale
$2,558 $3.17 p/Share
807 Reduced 0.28%
291,134 Common Stock
Aug 10 2023
SELL
Open market or private sale
$59,928 $3.54 p/Share
16,929 Reduced 5.48%
291,941 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
67,600 Added 17.96%
308,870 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$9,059 $6.38 p/Share
1,420 Reduced 0.59%
241,270 Common Stock
Jan 11 2023
SELL
Open market or private sale
$24,788 $7.8 p/Share
3,178 Reduced 1.29%
242,690 Common Stock
Nov 04 2022
SELL
Open market or private sale
$8,095 $6.41 p/Share
1,263 Reduced 0.51%
245,868 Common Stock
Aug 04 2022
SELL
Open market or private sale
$95,724 $4.39 p/Share
21,805 Reduced 8.11%
247,131 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
18,000 Added 6.27%
268,936 Common Stock
Jan 11 2022
SELL
Open market or private sale
$45,144 $9.64 p/Share
4,683 Reduced 1.86%
246,696 Common Stock
Jan 10 2022
SELL
Open market or private sale
$28,351 $9.32 p/Share
3,042 Reduced 1.2%
251,379 Common Stock
Dec 07 2021
SELL
Open market or private sale
$8,470 $10.18 p/Share
832 Reduced 0.33%
254,421 Common Stock
Nov 11 2021
BUY
Other acquisition or disposition
-
245,371 Added 49.01%
255,253 Common Stock
Aug 02 2021
BUY
Grant, award, or other acquisition
-
100,000 Added 41.74%
139,597 Common Stock
Jun 04 2021
SELL
Open market or private sale
$15,713 $30.75 p/Share
511 Reduced 1.27%
39,597 Common Stock
May 03 2021
SELL
Open market or private sale
$874 $30.15 p/Share
29 Reduced 0.07%
40,108 Common Stock
Apr 05 2021
SELL
Open market or private sale
$876 $30.21 p/Share
29 Reduced 0.07%
40,137 Common Stock
Mar 02 2021
SELL
Open market or private sale
$1,006 $29.58 p/Share
34 Reduced 0.08%
40,166 Common Stock
Feb 17 2021
SELL
Open market or private sale
$21,092 $28.16 p/Share
749 Reduced 1.83%
40,200 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
17,065 Added 29.42%
40,949 Common Stock
AO

Andrew Obenshain

President and CEO
Somerville, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLUE